Scientific journal paper Q1
Plasmodium falciparum genetic diversity in continental Equatorial Guinea before and after introduction of artemisinin based combination therapy
Mónica Guerra (Mónica Guerra); Rita Neres (Rita Neres); Patrícia Salgueiro (salgueiro, P.); Cristina Mendes (Cristina Mendes); Nicolas Ndong-Mabale (Nicolas Ndong-Mabale); Pedro Berzosa (Pedro Berzosa); Bruno de Sousa (Sousa, B.); Arez, Ana Paula (Arez, Ana Paula); et al.
Journal Title
Antimicrobial Agents and Chemotherapy
Year (definitive publication)
2017
Language
English
Country
United States of America
More Information
Web of Science®

Times Cited: 17

(Last checked: 2024-11-20 21:33)

View record in Web of Science®


: 0.5
Scopus

Times Cited: 17

(Last checked: 2024-11-19 09:12)

View record in Scopus


: 0.5
Google Scholar

Times Cited: 17

(Last checked: 2024-11-19 08:19)

View record in Google Scholar

Abstract
Efforts to control malaria may affect malaria parasite genetic variability and drug resistance, the latter of which is associated with genetic events that promote mechanisms to escape drug action. The worldwide spread of drug resistance has been a major obstacle to controlling Plasmodium falciparum malaria, and thus the study of the origin and spread of associated mutations may provide some insights into the prevention of its emergence. This study reports an analysis of P. falciparum genetic diversity, focusing on antimalarial resistance-associated molecular markers in two socioeconomically different villages in mainland Equatorial Guinea. The present study took place 8 years after a previous one, allowing the analysis of results before and after the introduction of an artemisinin-based combination therapy (ACT), i.e., artesunate plus amodiaquine. Genetic diversity was assessed by analysis of the Pfmsp2 gene and neutral microsatellite loci. Pfdhps and Pfdhfr alleles associated with sulfadoxine-pyrimethamine (SP) resistance and flanking microsatellite loci were investigated, and the prevalences of drug resistance-associated point mutations of the Pfcrt, Pfmdr1, Pfdhfr, and Pfdhps genes were estimated. Further, to monitor the use of ACT, we provide the baseline prevalences of K13 propeller mutations and Pfmdr1 copy numbers. After 8 years, noticeable differences occurred in the distribution of genotypes conferring resistance to chloroquine and SP, and the spread of mutated genotypes differed according to the setting. Regarding artemisinin resistance, although mutations reported as being linked to artemisinin resistance were not present at the time, several single nucleotide polymorphisms (SNPs) were observed in the K13 gene, suggesting that closer monitoring should be maintained to prevent the possible spread of artemisinin resistance in Africa.
Acknowledgements
--
Keywords
ACT introduction,drug resistance molecular markers,Equatorial Guinea,genetic diversity,malaria,neutral and flanking microsatellites,Plasmodium falciparum,Pfcrt,Pfdhps,Pfdhfr,Pfmdr1,Kelch propeller protein K13 polymorphisms
  • Chemical Sciences - Natural Sciences
  • Biological Sciences - Natural Sciences
  • Health Sciences - Medical and Health Sciences
  • Other Medical Sciences - Medical and Health Sciences

With the objective to increase the research activity directed towards the achievement of the United Nations 2030 Sustainable Development Goals, the possibility of associating scientific publications with the Sustainable Development Goals is now available in Ciência-IUL. These are the Sustainable Development Goals identified by the author(s) for this publication. For more detailed information on the Sustainable Development Goals, click here.